Another Delaware Publicly Traded Company Proposes A Nevada Move
JD Supra: Mergers
SEPTEMBER 17, 2024
Last week, Chromocell Therapeutics Corporation filed preliminary proxy materials that included a proposal to reincorporate in Nevada. The proposal also contemplates a simultaneous name change to “Channel Therapeutics Corporation”. The proposal also contemplates a simultaneous name change to “Channel Therapeutics Corporation”.
Let's personalize your content